Engage Therapeutics hauls in $23 mln Series A

Summit, New Jersey-based Engage Therapeutics Inc, a developer of treatments for people who experience uncontrolled epileptic seizures, has secured $23 million in Series A financing. TPG Biotech led the round with participation from Adage Capital Management and Lumira Capital. LifeSci Capital was the lead placement agent.

ManagersNorth AmericaUSHealthcareBriefs